US Patent Issued to Max-Planck-Gesellschaft zur Forderung der Wissenschaften on July 21 for "Small molecules for increasing precise genome editing efficiency" (German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,875, issued on July 21, was assigned to Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. (Munich).

"Small molecules for increasing precise genome editing efficiency" was invented by Stephan Riesenberg (Jena, Germany) and Tomislav Maricic (Leipzig, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds suitable to increase precise genome editing efficiency in a eukaryotic target cell or target organism. Thus, the present invention can be applied in gene therapy."

The patent was filed on Dec. 19, 2019, under Application No. 17/416,949.

*For further information, including images, charts and tabl...